{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Curcuminoids", "JAK/STAT pathway", "PI3K/Akt/mTOR", "chemotherapeutic agent", "miRNAs.", "signaling pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37559247", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "26"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/0929867331666230809100335"], "Journal": {"ISSN": "1875-533X", "JournalIssue": {"Volume": "31", "Issue": "21", "PubDate": {"Year": "2024"}}, "Title": "Current medicinal chemistry", "ISOAbbreviation": "Curr Med Chem"}, "ArticleTitle": "Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention.", "Pagination": {"StartPage": "3093", "EndPage": "3117", "MedlinePgn": "3093-3117"}, "Abstract": {"AbstractText": ["Despite substantial advancements in curative modern medicine in the last few decades, cancer risk and casualty rates have continued to mount globally. The exact reason for cancer's onset and progression is still unknown. However, skeletal and functional abnormalities in the genetic code are assumed to be the primary cause of cancer. Many lines of evidence reported that some medicinal plants can be utilized to curb cancer cell proliferation with a safe, fruitful, and cost-efficient perspective. Curcuminoid, isolated from <i>Curcuma longa</i>, have gotten a lot of focus due to their anticancer potential as they reduce tumor progression, invasion, and dissemination. Further, they modulated signal transduction routes like MAPK, PI3K/Akt/mTOR, JAK/STAT, and Wnt/\u03b2-catenin, etc., and triggered apoptosis as well as actuated autophagy in malignant cells without altering the normal cells, thus preventing cancer progression. Besides, Curcuminoid also regulate the function and expression of anti-tumor and carcinogenic miRNAs. Clinical studies also reported the therapeutic effect of Curcuminoid against various cancer through decreasing specific biomarkers like TNF-\u03b1, Bcl-2, COX-2, PGE2, VEGF, I\u03baK\u03b2, and various cytokines like IL-12p70, IL-10, IL-2, IFN-\u03b3 levels and increasing in p53 and Bax levels. Thus, in the present review, we abridged the modulation of several signal transduction routes by Curcuminoids in various malignancies, and its modulatory role in the initiation of tumor-suppressive miRNAs and suppression of the oncogenic miRNAs are explored. Additionally, various pharmacokinetic approaches have been projected to address the Curcuminoids bioavailability like the use of piperine as an adjuvant; nanotechnology- based Curcuminoids preparations utilizing Curcuminoids analogues are also discussed."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Laboratory, Department of Pharmaceutical Sciences, School of Applied Sciences & Technology, University of Kashmir, Hazratbal Srinagar, J&K, India."}], "LastName": "Noor", "ForeName": "Aneeza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Laboratory, Department of Pharmaceutical Sciences, School of Applied Sciences & Technology, University of Kashmir, Hazratbal Srinagar, J&K, India."}], "LastName": "Shafi", "ForeName": "Saimeena", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Translational and Clinical Research, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi 110062, India."}], "LastName": "Sehar", "ForeName": "Nouroz", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Laboratory, Department of Pharmaceutical Sciences, School of Applied Sciences & Technology, University of Kashmir, Hazratbal Srinagar, J&K, India."}], "LastName": "Qadir", "ForeName": "Insha", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Laboratory, Department of Pharmaceutical Sciences, School of Applied Sciences & Technology, University of Kashmir, Hazratbal Srinagar, J&K, India."}], "LastName": "Bilquees"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology & Toxicology, College of Pharmacy, Prince Sattam Bin Abdul Aziz University, Al Kharj, 11942, Saudi Arabia."}], "LastName": "Rashid", "ForeName": "Summya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Arafah", "ForeName": "Azher", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of School Education, Govt. of Jammu & Kashmir, Srinagar, J&K 190001, India."}], "LastName": "Rasool", "ForeName": "Saiema", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular Neurobiology Laboratory (CNB-P), Salk Institute, 10010 N. Torrey Pines Rd., La Jolla, CA92037, USA."}], "LastName": "Dar", "ForeName": "Nawab John", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Laboratory, Department of Pharmaceutical Sciences, School of Applied Sciences & Technology, University of Kashmir, Hazratbal Srinagar, J&K, India."}], "LastName": "Masoodi", "ForeName": "Mubashir Hussain", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Rehman", "ForeName": "Muneeb U", "Initials": "MU"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Med Chem", "NlmUniqueID": "9440157", "ISSNLinking": "0929-8673"}, "ChemicalList": [{"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug therapy", "prevention & control", "metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology", "chemistry", "therapeutic use", "analogs & derivatives"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Afshari A.R.; Jalili-Nik M.; Abbasinezhad-Moud F.; Javid H.; Karimi M.; Mollazadeh H.; Jamialahmadi T.; Sathyapalan T.; Sahebkar A.; Anti-tumor effects of curcuminoids in glioblastoma multiforme: an updated literature review. Curr Med Chem 2021,28(39),8116-8138", "ArticleIdList": ["10.2174/1875533XMTExtNDA8x", "33176632"]}, {"Citation": "Ferlay J.; Colombet M.; Soerjomataram I.; Parkin D.M.; Pi\u00f1eros M.; Znaor A.; Bray F.; Cancer statistics for the year 2020: An overview. Int J Cancer 2021,149(4),778-789", "ArticleIdList": ["10.1002/ijc.33588", "33818764"]}, {"Citation": "Srivastava N.S.; Srivastava R.A.K.; Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/\u03b2-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 2019,52,117-128", "ArticleIdList": ["10.1016/j.phymed.2018.09.224", "30599890"]}, {"Citation": "Wei M.M.; Zhao S.J.; Dong X.M.; Wang Y.J.; Fang C.; Wu P.; Song G.Q.; Gao J.N.; Huang Z.H.; Xie T.; Zhou J.L.; A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells. J Ethnopharmacol 2021,267,113467", "ArticleIdList": ["10.1016/j.jep.2020.113467", "33058923"]}, {"Citation": "Bordoloi D.; Roy N.K.; Monisha J.; Padmavathi G.; Kunnumakkara A.B.; Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far. Recent Pat Anticancer Drug Discov 2016,11(1),67-97", "ArticleIdList": ["10.2174/1574892810666151020101706", "26537958"]}, {"Citation": "Xu X.; Qin J.; Liu W.; Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene 2014,546(2),226-232", "ArticleIdList": ["10.1016/j.gene.2014.06.006", "24910117"]}, {"Citation": "Tuyaerts S.; Rombauts K.; Everaert T.; Van Nuffel A.M.T.; Amant F.; A phase 2 study to assess the immunomodulatory capacity of a lecithin-based delivery system of curcumin in endometrial cancer. Front Nutr 2019,5,138", "ArticleIdList": ["10.3389/fnut.2018.00138", "30687714"]}, {"Citation": "Mollazadeh H.; Cicero A.F.G.; Blesso C.N.; Pirro M.; Majeed M.; Sahebkar A.; Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr 2019,59(1),89-101", "ArticleIdList": ["10.1080/10408398.2017.1358139", "28799796"]}, {"Citation": "Almatroodi S.A.; Alrumaihi F.; Alsahli M.A.; Alhommrani M.F.; Khan A.; Rahmani A.H.; Curcumin, an active constituent of turmeric spice: implication in the prevention of lung injury induced by benzo (a) pyrene (BaP) in rats. Molecules 2020,25(3),724", "ArticleIdList": ["10.3390/molecules25030724", "32046055"]}, {"Citation": "Ma C.; Zhuang Z.; Su Q.; He J.; Li H.; Curcumin has anti-proliferative and pro-apoptotic effects on tongue cancer in vitro: A study with bioinformatics analysis and in vitro experiments. Drug Des Devel Ther 2020,14,509-518", "ArticleIdList": ["10.2147/DDDT.S237830", "32099333"]}, {"Citation": "Fu Y.S.; Chen T.H.; Weng L.; Huang L.; Lai D.; Weng C.F.; Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomed Pharmacother 2021,141,111888", "ArticleIdList": ["10.1016/j.biopha.2021.111888", "34237598"]}, {"Citation": "Chen L.; Zhan C.Z.; Wang T.; You H.; Yao R.; Curcumin inhibits the proliferation, migration, invasion, and apoptosis of diffuse large B-cell lymphoma cell line by regulating MiR-21/VHL axis. Yonsei Med J 2020,61(1),20-29", "ArticleIdList": ["10.3349/ymj.2020.61.1.20", "31887796"]}, {"Citation": "Dimri M.; Satyanarayana A.; Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma. Cancers 2020,12(2),491", "ArticleIdList": ["10.3390/cancers12020491", "32093152"]}, {"Citation": "Sultana S.; Munir N.; Mahmood Z.; Riaz M.; Akram M.; Rebezov M.; Kuderinova N.; Moldabayeva Z.; Shariati M.A.; Rauf A.; Rengasamy K.R.R.; Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A review. Biomed Pharmacother 2021,135,111078", "ArticleIdList": ["10.1016/j.biopha.2020.111078", "33433356"]}, {"Citation": "Lee S.Y.; Cho S.S.; Li Y.; Bae C.S.; Park K.M.; Park D.H.; Anti-inflammatory effect of curcuma longa and allium hookeri co-treatment via NF-\u03baB and COX-2 pathways. Sci Rep 2020,10(1),5718", "ArticleIdList": ["10.1038/s41598-020-62749-7", "31913322"]}, {"Citation": "Bhatia M.; Bhalerao M.; Cruz-Martins N.; Kumar D.; Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways. Phytother Res 2021,35(9),4913-4929", "ArticleIdList": ["10.1002/ptr.7121"]}, {"Citation": "KM M.; Palaniswamy D.S.; NP D.; Jyothi D.P.; Therapeutic importance of curcumin with a special emphasis on mdr cancer cells and the factors influencing pharmacodynamics. Indones J Pharm 2021,429-441", "ArticleIdList": ["10.22146/ijp.2280"]}, {"Citation": "Jamialahmadi T.; Guest P.C.; Tasbandi A.; Majeed M.; Sahebkar A.; Physical Exercise and Natural and Synthetic Products in Health and Disease 2022,319-330", "ArticleIdList": ["10.1007/978-1-0716-1558-4_23"]}, {"Citation": "Noorolyai S.; Shajari N.; Baghbani E.; Sadreddini S.; Baradaran B.; The relation between PI3K/AKT signalling pathway and cancer. Gene 2019,698,120-128", "ArticleIdList": ["10.1016/j.gene.2019.02.076"]}, {"Citation": "Cheng J.; Huang Y.; Zhang X.; Yu Y.; Wu S.; Jiao J.; Tran L.; Zhang W.; Liu R.; Zhang L.; Wang M.; Wang M.; Yan W.; Wu Y.; Chi F.; Jiang P.; Zhang X.; Wu H.; TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism. Nat Commun 2020,11(1),1880", "ArticleIdList": ["10.1038/s41467-020-15819-3", "32312982"]}, {"Citation": "Hu S.; Xu Y.; Meng L.; Huang L.; Sun H.; Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Exp Ther Med 2018,16(2),1266-1272", "ArticleIdList": ["10.3892/etm.2018.6345", "30116377"]}, {"Citation": "Farghadani R.; Naidu R.; Curcumin: Modulator of key molecular signaling pathways in hormone-independent breast cancer. Cancers 2021,13(14),3427", "ArticleIdList": ["10.3390/cancers13143427", "34298639"]}, {"Citation": "Badr G.; Gul H.I.; Yamali C.; Mohamed A.A.M.; Badr B.M.; Gul M.; Abo Markeb A.; Abo El-Maali N.; Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells. Bioorg Chem 2018,78,46-57", "ArticleIdList": ["10.1016/j.bioorg.2018.03.006", "29533214"]}, {"Citation": "Ashrafizadeh M.; Najafi M.; Makvandi P.; Zarrabi A.; Farkhondeh T.; Samarghandian S.; Versatile role of curcumin and its derivatives in lung cancer therapy. J Cell Physiol 2020,235(12),241-9268", "ArticleIdList": ["10.1002/jcp.29819"]}, {"Citation": "Zhang Q.; Qiao H.; Wu D.; Lu H.; Liu L.; Sang X.; Li D.; Zhou Y.; Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt/mTOR signaling pathway. Life Sci 2019,239,117044", "ArticleIdList": ["10.1016/j.lfs.2019.117044", "31715187"]}, {"Citation": "Song G.; Lu H.; Chen F.; Wang Y.; Fan W.; Shao W.; Lu H.; Lin B.; Tetrahydrocurcumin-induced autophagy via suppression of PI3K/Akt/mTOR in non-small cell lung carcinoma cells. Mol Med Rep 2018,17(4),5964-5969", "ArticleIdList": ["10.3892/mmr.2018.8600", "29436654"]}, {"Citation": "Wang H.J.; Yang Z.X.; Dai X.T.; Chen Y.F.; Yang H.P.; Zhou X.D.; Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Apoptosis 2017,22(9),1157-1168", "ArticleIdList": ["10.1007/s10495-017-1395-x", "28677094"]}, {"Citation": "Chen Y.; Wu M.; Demethoxycurcumin inhibits the growth of human lung cancer cells by targeting of PI3K/AKT/m- TOR signalling pathway, induction of apoptosis and inhibition of cell migration and invasion. Trop J Pharm Res 2022,20(4),687-693", "ArticleIdList": ["10.4314/tjpr.v20i4.4"]}, {"Citation": "Lee H.Y.J.; Meng M.; Liu Y.; Su T.; Kwan H. Y.; Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer (Review). Oncol Lett 2021,22(3),646", "ArticleIdList": ["10.3892/ol.2021.12907"]}, {"Citation": "Wang J.; Wang C.; Bu G.; Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Exp Ther Med 2018,15(4),3650-3658", "ArticleIdList": ["10.3892/etm.2018.5805", "29545895"]}, {"Citation": "Zhu X.; Zhu R.; Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway. OncoTargets Ther 2018,11,3521-3531", "ArticleIdList": ["10.2147/OTT.S159236", "29950857"]}, {"Citation": "Wang Y.; Lu J.; Jiang B.; Guo J.; The roles of curcumin in regulating the tumor immunosuppressive microenvironment (Review). Oncol Lett 2020,19(4),3059-3070", "ArticleIdList": ["10.3892/ol.2020.11437"]}, {"Citation": "Li W.; Jiang Z.; Xiao X.; Wang Z.; Wu Z.; Ma Q.; Cao L.; Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-\u03baB pathway in pancreatic cancer cells. Int J Oncol 2018,52(5),1593-1602", "ArticleIdList": ["10.3892/ijo.2018.4295", "29512729"]}, {"Citation": "Hamzehzadeh L.; Atkin S.L.; Majeed M.; Butler A.E.; Sahebkar A.; The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway. J Cell Physiol 2018,233(10),6530-6537", "ArticleIdList": ["10.1002/jcp.26620"]}, {"Citation": "Wahab N.A.A.; Lajis N.H.; Abas F.; Othman I.; Naidu R.; Mechanism of anti-cancer activity of curcumin on androgen-dependent and androgen-independent prostate cancer. Nutrients 2020,12(3),679", "ArticleIdList": ["10.3390/nu12030679"]}, {"Citation": "Gong X.; Jiang L.; Li W.; Liang Q.; Li Z.; Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt/mTOR suppression. Bioengineered 2021,12(1),5017-5027", "ArticleIdList": ["10.1080/21655979.2021.1960765", "34402718"]}, {"Citation": "Wong S.C.; Kamarudin M.N.A.; Naidu R.; Anticancer mechanism of curcumin on human glioblastoma. Nutrients 2021,13(3),950", "ArticleIdList": ["10.3390/nu13030950", "33809462"]}, {"Citation": "Wang R.; Li J.; Zhao Y.; Li Y.; Yin L.; Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis. Breast Cancer 2018,25(2),206-212", "ArticleIdList": ["10.1007/s12282-017-0816-6", "29139094"]}, {"Citation": "Adewumi H.; Carter G.; Bhuiyan S.; College J. C.; Bioresearch communications curcumin downregulates the expression of p44 / 42 MAPK and causes caspase-mediated cell inhibition in MCF-7 breast cancer cells. Cancer Cells 2020,06(01),2020-2021"}, {"Citation": "Mao M.; Dengdi H.; Jingjing Y.; Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change. J Mol Med 2021,99(6),845-858", "ArticleIdList": ["10.1007/s00109-021-02047-5"]}, {"Citation": "Sun M.; Zhang Y.; He Y.; Xiong M.; Huang H.; Pei S.; Liao J.; Wang Y.; Shao D.; Green synthesis of carrier-free curcumin nanodrugs for light-activated breast cancer photodynamic therapy. Colloids Surf B Biointerfaces 2019,180(March),313-318", "ArticleIdList": ["10.1016/j.colsurfb.2019.04.061", "31071571"]}, {"Citation": "Hsieh M.; Lu C.; Kuo S.; Next-generation sequencing analysis reveals that MTH-3, a novel curcuminoid derivative,suppresses the invasion of MDA-MB-231 triple-negative breast adenocarcinoma cells. Oncol Rep 2021,1-17", "ArticleIdList": ["10.3892/or.2021.8084"]}, {"Citation": "Shen X.; Sun X.; Chen H.; Lu B.; Qin Y.; Zhang C.; Liang G.; Wang J.; Yu P.; Su L.; Ma Q.; Li Y.; Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition. Cancer Chemother Pharmacol 2021,87(4),487-499", "ArticleIdList": ["10.1007/s00280-020-04198-7", "33403398"]}, {"Citation": "Liang Z.; Rui Z.; Wei X.; Curcumin reverses tobacco smoke-induced epithelial-mesenchymal transition by suppressing the MAPK pathway in the lungs of mice. Mol Med Rep 2017,17(1),2019-2025", "ArticleIdList": ["10.3892/mmr.2017.8028", "29138815"]}, {"Citation": "Chien M.H.; Yang W.E.; Yang Y.C.; Ku C.C.; Lee W.J.; Tsai M.Y.; Lin C.W.; Yang S.F.; Dual targeting of the p38 MAPK-HO-1 axis and cIAP1/XIAP by demethoxycurcumin triggers caspase-mediated apoptotic cell death in oral squamous cell carcinoma cells. Cancers 2020,12(3),703", "ArticleIdList": ["10.3390/cancers12030703", "32188144"]}, {"Citation": "Shi L.; Sun G.; Zhu H.; Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling. Aging 2020,12(14),14718-14735", "ArticleIdList": ["10.18632/aging.103531", "32710727"]}, {"Citation": "Hsiao P.C.; Chang J.H.; Lee W.J.; Ku C.C.; Tsai M.Y.; Yang S.F.; Chien M.H.; The curcumin analogue, ef-24, triggers p38 mapkmediated apoptotic cell death via inducing pp2amodulated erk deactivation in human acute myeloid leukemia cells. Cancers 2020,12(8),2163", "ArticleIdList": ["10.3390/cancers12082163", "32759757"]}, {"Citation": "Agarwal A.; Kasinathan A.; Ganesan R.; Balasubramanian A.; Bhaskaran J.; Suresh S.; Srinivasan R.; Aravind K.B.; Sivalingam N.; Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species\u2013independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells. Nutr Res 2018,51,67-81", "ArticleIdList": ["10.1016/j.nutres.2017.12.011", "29673545"]}, {"Citation": "Huang C.; Lu H.F.; Chen Y.H.; Chen J.C.; Chou W.H.; Huang H.C.; Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and \u2013independent apoptosis via Smad or Akt signaling pathways in HOS cells. BMC Complement Med Ther 2020,20(1),68", "ArticleIdList": ["10.1186/s12906-020-2857-1", "32126993"]}, {"Citation": "Chen Y.Y.; Lin Y.J.; Huang W.T.; Hung C.C.; Lin H.Y.; Tu Y.C.; Liu D.M.; Lan S.J.; Sheu M.J.; Demethoxycurcumin-loaded chitosan nanoparticle downregulates DNA repair pathway to improve cisplatin-induced apoptosis in non-small cell lung cancer. Molecules 2018,23(12),3217", "ArticleIdList": ["10.3390/molecules23123217", "30563166"]}, {"Citation": "Xiang M.; Jiang H.G.; Shu Y.; Chen Y.J.; Jin J.; Zhu Y.M.; Li M.Y.; Wu J.N.; Li J.; Bisdemethoxycurcumin enhances the sensitivity of non-small cell lung cancer cells to icotinib via dual induction of autophagy and apoptosis. Int J Biol Sci 2020,16(9),1536-1550", "ArticleIdList": ["10.7150/ijbs.40042", "32226300"]}, {"Citation": "Hsiao Y.T.; Kuo C.L.; Chueh F.S.; Liu K.C.; Bau D.T.; Chung J.G.; Curcuminoids induce reactive oxygen species and autophagy to enhance apoptosis in human oral cancer cells. Am J Chin Med 2018,46(5),1145-1168", "ArticleIdList": ["10.1142/S0192415X1850060X", "29976081"]}, {"Citation": "Kao C.C.; Cheng Y.C.; Yang M.H.; Cha T.L.; Sun G.H.; Ho C.T.; Lin Y.C.; Wang H.K.; Wu S.T.; Way T.D.; Demethoxycurcumin induces apoptosis in overexpressing bladder cancer cells through degradation of and inhibiting the /Akt pathway. Environ Toxicol 2021,36(11),2186-2195", "ArticleIdList": ["10.1002/tox.23332", "34291863"]}, {"Citation": "Qiang Z.; Meng L.; Yi C.; Yu L.; Chen W.; Sha W.; Curcumin regulates the miR-21/PTEN/Akt pathway and acts in synergy with PD98059 to induce apoptosis of human gastric cancer MGC-803 cells. J Int Med Res 2019,47(3),1288-1297", "ArticleIdList": ["10.1177/0300060518822213", "30727807"]}, {"Citation": "Hsia T.C.; Peng S.F.; Chueh F.S.; Lu K.W.; Yang J.L.; Huang A.C.; Hsu F.T.; Wu R.S.C.; Bisdemethoxycurcumin induces cell apoptosis and inhibits human brain glioblastoma GBM 8401/Luc2 cell xenograft tumor in subcutaneous nude mice in vivo. Int J Mol Sci 2022,23(1),538", "ArticleIdList": ["10.3390/ijms23010538", "35008959"]}, {"Citation": "Verzella D.; Alessandra P.; Daria C.; Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere. Cell Death Dis 2020,11(3),210", "ArticleIdList": ["10.1038/s41419-020-2399-y"]}, {"Citation": "Xu J.H.; Yang H.P.; Zhou X.D.; Wang H.J.; Gong L.; Tang C.L.; Autophagy accompanied with bisdemethoxycurcumin-induced apoptosis in non-small cell lung cancer cells. Biomed Environ Sci 2015,28(2),105-115", "ArticleIdList": ["10.3967/bes2015.013", "25716561"]}, {"Citation": "Liu F.; Gao S.; Yang Y.; Zhao X.; Fan Y.; Ma W.; Yang D.; Yang A.; Yu Y.; Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549. Oncol Lett 2017,14(3),2775-2782", "ArticleIdList": ["10.3892/ol.2017.6565", "28928819"]}, {"Citation": "Mao X.; Zhang X.; Zheng X.; Chen Y.; Xuan Z.; Huang P.; Curcumin suppresses LGR5(+) colorectal cancer stem cells by inducing autophagy and via repressing TFAP2A-mediated ECM pathway. J Nat Med 2021,75(3),590-601", "ArticleIdList": ["10.1007/s11418-021-01505-1", "33713277"]}, {"Citation": "Liu L.D.; Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT/mTOR/p70S6K pathway in human ovarian cancer cells. Arch Gynecol Obstet 2019,299(6),1627-1639", "ArticleIdList": ["10.1007/s00404-019-05058-3"]}, {"Citation": "Fu H.; Wang C.; Yang D.; Wei Z.; Xu J.; Hu Z.; Zhang Y.; Wang W.; Yan R.; Cai Q.; Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J Cell Physiol 2018,233(6),4634-4642", "ArticleIdList": ["10.1002/jcp.26190", "28926094"]}, {"Citation": "Diederich ; Gaascht F.; Cronauer M.; Henry E.; Dicato M.; Diederich M.; Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 2011,38(3),603-611", "ArticleIdList": ["10.3892/ijo.2011.905", "21240460"]}, {"Citation": "Yang C.; Ma X.; Wang Z.; Zeng X.; Hu Z.; Ye Z.; Shen G.; Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation. Drug Des Devel Ther 2017,11,431-439", "ArticleIdList": ["10.2147/DDDT.S126964", "28243065"]}, {"Citation": "Lin H.Y.; Lin J-N.; Ma J-W.; Yang N-S.; Ho C-T.; Kuo S-C.; Way T-D.; Demethoxycurcumin induces autophagic and apoptotic responses on breast cancer cells in photodynamic therapy. J Funct Foods 2015,12,439-449", "ArticleIdList": ["10.1016/j.jff.2014.12.014"]}, {"Citation": "Wang K.; Zhang C.; Bao J.; Jia X.; Liang Y.; Wang X.; Chen M.; Su H.; Li P.; Wan J.B.; He C.; Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 2016,6(1),26064", "ArticleIdList": ["10.1038/srep26064", "27263652"]}, {"Citation": "Qureshy Z.; Johnson D.E.; Grandis J.R.; Targeting the JAK/STAT pathway in solid tumors. J Cancer Metastasis Treat 2020,2020,1-29", "ArticleIdList": ["10.20517/2394-4722.2020.58", "33521321"]}, {"Citation": "Wang J.; Zhang Y.; Song H.; Yin H.; Jiang T.; Xu Y.; Liu L.; Wang H.; Gao H.; Wang R.; Song J.; The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway. Mol Cancer 2021,20(1),81", "ArticleIdList": ["10.1186/s12943-021-01375-x", "34074294"]}, {"Citation": "Wang H.; Zhang K.; Liu J.; Yang J.; Tian Y.; Yang C.; Li Y.; Shao M.; Su W.; Song N.; Curcumin regulates cancer progression: Focus on ncRNAs and molecular signaling pathways. Front Oncol 2021,11,660712", "ArticleIdList": ["10.3389/fonc.2021.660712", "33912467"]}, {"Citation": "Li Y.; Sun W.; Han N.; Zou Y.; Yin D.; Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway. BMC Cancer 2018,18(1),1230", "ArticleIdList": ["10.1186/s12885-018-5130-y", "30526546"]}, {"Citation": "Weissenberger J.; Priester M.; Bernreuther C.; Rakel S.; Glatzel M.; Seifert V.; K\u00f6gel D.; Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway. Clin Cancer Res 2010,16(23),5781-5795", "ArticleIdList": ["10.1158/1078-0432.CCR-10-0446", "21138870"]}, {"Citation": "Leng L.; Zhong X.; Sun G.; Qiu W.; Shi L.; Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo. Tumour Biol 2016,37(12),15847-15857", "ArticleIdList": ["10.1007/s13277-016-5399-x", "27757851"]}, {"Citation": "Bharti A.C.; Donato N.; Aggarwal B.B.; Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003,171(7),3863-3871", "ArticleIdList": ["10.4049/jimmunol.171.7.3863", "14500688"]}, {"Citation": "Chen J.; Wang F.L.; Chen W.D.; Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Mol Biol Rep 2014,41(7),4583-4594", "ArticleIdList": ["10.1007/s11033-014-3329-9", "24604727"]}, {"Citation": "Tang L.; Liu J.; Zhu L.; Chen Q.; Meng Z.; Sun L.; Hu J.; Ni Z.; Wang X.; Curcumin inhibits growth of human NCI-H292 lung squamous cell carcinoma cells by increasing FOXA2 expression. Front Pharmacol 2018,9(FEB),60", "ArticleIdList": ["10.3389/fphar.2018.00060", "29456509"]}, {"Citation": "Alexandrow M.G.; Song L.J.; Altiok S.; Gray J.; Haura E.B.; Kumar N.B.; Curcumin. Eur J Cancer Prev 2012,21(5),407-412", "ArticleIdList": ["10.1097/CEJ.0b013e32834ef194", "22156994"]}, {"Citation": "Hu A.; Huang J.J.; Jin X.J.; Li J.P.; Tang Y.J.; Huang X.F.; Cui H.J.; Xu W.H.; Sun G.B.; Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway. Am J Cancer Res 2014,5(1),278-288", "ArticleIdList": ["25628937"]}, {"Citation": "Selvendiran K.; Tong L.; Bratasz A.; Kuppusamy M.L.; Ahmed S.; Ravi Y.; Trigg N.J.; Rivera B.K.; K\u00e1lai T.; Hideg K.; Kuppusamy P.; Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts. Mol Cancer Ther 2010,9(5),1169-1179", "ArticleIdList": ["10.1158/1535-7163.MCT-09-1207", "20442315"]}, {"Citation": "Pan Y.; Sun Y.; Liu Z.; Zhang C.; miR-192-5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c-Myc and inactivating the Wnt/\u03b2-catenin signaling pathway. Mol Med Rep 2020,22(2),1594-1604", "ArticleIdList": ["10.3892/mmr.2020.11213", "32626956"]}, {"Citation": "Zhang Y.; Wang X.; Targeting the Wnt/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol 2020,13(1),165", "ArticleIdList": ["10.1186/s13045-020-00990-3", "33276800"]}, {"Citation": "Li B.; Shi C.; Li B.; Zhao J.M.; Wang L.; The effects of curcumin on HCT-116 cells proliferation and apoptosis via the miR-491/PEG10 pathway. J Cell Biochem 2018,119(4),3091-3098", "ArticleIdList": ["10.1002/jcb.26449", "29058812"]}, {"Citation": "Ryu M.J.; Cho M.; Song J.Y.; Yun Y.S.; Choi I.W.; Kim D.E.; Park B.S.; Oh S.; Natural derivatives of curcumin attenuate the Wnt/\u03b2-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 2008,377(4),1304-1308", "ArticleIdList": ["10.1016/j.bbrc.2008.10.171", "19000900"]}, {"Citation": "Marjaneh R.M.; Rahmani F.; Hassanian S.M.; Rezaei N.; Hashemzehi M.; Bahrami A.; Ariakia F.; Fiuji H.; Sahebkar A.; Avan A.; Khazaei M.; Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. J Cell Physiol 2018,233(10),6785-6798", "ArticleIdList": ["10.1002/jcp.26538", "29737515"]}, {"Citation": "Prasad C.P.; Rath G.; Mathur S.; Bhatnagar D.; Ralhan R.; Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/\u03b2-catenin signaling. Chem Biol Interact 2009,181(2),263-271", "ArticleIdList": ["10.1016/j.cbi.2009.06.012", "19573523"]}, {"Citation": "Leow P.C.; Tian Q.; Ong Z.Y.; Yang Z.; Ee P.L.R.; Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/\u03b2-catenin antagonists against human osteosarcoma cells. Invest New Drugs 2010,28(6),766-782", "ArticleIdList": ["10.1007/s10637-009-9311-z", "19730790"]}, {"Citation": "He M.; Li Y.U.; Zhang L.I.; Li L.; Shen Y.I.; Lin L.; Zheng W.; Chen L.I.; Bian X.; Ng H.K.; Tang L.I.; Curcumin suppresses cell proliferation through inhibition of the Wnt/\u03b2-catenin signaling pathway in medulloblastoma. Oncol Rep 2014,32(1),173-180", "ArticleIdList": ["10.3892/or.2014.3206", "24858998"]}, {"Citation": "Yan C.; Jamaluddin M.S.; Aggarwal B.; Myers J.; Boyd D.D.; Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 2005,4(2),233-241", "ArticleIdList": ["10.1158/1535-7163.233.4.2", "15713895"]}, {"Citation": "Qian C.; Wang B.; Zou Y.; Zhang Y.; Hu X.; Sun W.; Xiao H.; Liu H.; Shi L.; MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin. Cancer Manag Res 2019,11,6829-6840", "ArticleIdList": ["10.2147/CMAR.S210076", "31440081"]}, {"Citation": "Zheng R.; Deng Q.; Liu Y.; Zhao P.; Curcumin inhibits gastric carcinoma cell growth and induces apoptosis by suppressing the Wnt/\u03b2-Catenin signaling pathway. Med Sci Monit 2017,23,163-171", "ArticleIdList": ["10.12659/MSM.902711", "28077837"]}, {"Citation": "Kim H.J.; Park S.Y.; Park O.J.; Kim Y.M.; Curcumin suppresses migration and proliferation of Hep3B hepatocarcinoma cells through inhibition of the Wnt signaling pathway. Mol Med Rep 2013,8(1),282-286", "ArticleIdList": ["10.3892/mmr.2013.1497", "23723038"]}, {"Citation": "Leichter A.L.; Sullivan M.J.; Eccles M.R.; Chatterjee A.; MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Mol Cancer 2017,16(1),15", "ArticleIdList": ["10.1186/s12943-017-0584-0", "28103887"]}, {"Citation": "Zang H.; Peng J.; Wang W.; Fan S.; Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer. J Cancer 2017,8(18),3856-3861", "ArticleIdList": ["10.7150/jca.21267", "29151973"]}, {"Citation": "Momtazi A.A.; Shahabipour F.; Khatibi S.; Johnston T.P.; Pirro M.; Sahebkar A.; Curcumin as a microRNA regulator in cancer: A review. Rev Physiol Biochem Pharmacol 2016,171,1-38", "ArticleIdList": ["10.1007/112_2016_3", "27457236"]}, {"Citation": "Du Z.; Sha X.; Demethoxycurcumin inhibited human epithelia ovarian cancer cells\u2019 growth via up-regulating miR-551a. Tumour Biol 2017,39(3),1010428317694302", "ArticleIdList": ["10.1177/1010428317694302", "28345465"]}, {"Citation": "Sun M.; Estrov Z.; Ji Y.; Coombes K.R.; Harris D.H.; Kurzrock R.; Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 2008,7(3),464-473", "ArticleIdList": ["10.1158/1535-7163.MCT-07-2272", "18347134"]}, {"Citation": "Ali S.; Ahmad A.; Banerjee S.; Padhye S.; Dominiak K.; Schaffert J.M.; Wang Z.; Philip P.A.; Sarkar F.H.; Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 2010,70(9),3606-3617", "ArticleIdList": ["10.1158/0008-5472.CAN-09-4598", "20388782"]}, {"Citation": "Wang H.; Cai X.; Ma L.; Curcumin modifies epithelial\u2013mesenchymal transition in colorectal cancer through regulation of mir-200c/epm5. Cancer Manag Res 2020,12,9405-9415", "ArticleIdList": ["10.2147/CMAR.S260129", "33061628"]}, {"Citation": "Pan L.; Sha J.; Lin W.; Wang Y.; Bian T.; Guo J.; Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis. Exp Ther Med 2021,22(3),969", "ArticleIdList": ["10.3892/etm.2021.10401", "34335911"]}, {"Citation": "Yang C.H.; Yue J.; Sims M.; Pfeffer L.M.; The curcumin analog EF24 targets NF-\u03baB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One 2013,8(8),e71130", "ArticleIdList": ["10.1371/journal.pone.0071130", "23940701"]}, {"Citation": "Dahmke I.N.; Backes C.; Rudzitis-Auth J.; Laschke M.W.; Leidinger P.; Menger M.D.; Meese E.; Mahlknecht U.; Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered. PLoS One 2013,8(12),e81122", "ArticleIdList": ["10.1371/journal.pone.0081122", "24349037"]}, {"Citation": "Zhang J.; Zhang T.; Ti X.; Shi J.; Wu C.; Ren X.; Yin H.; Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Commun 2010,399(1),1-6", "ArticleIdList": ["10.1016/j.bbrc.2010.07.013", "20627087"]}, {"Citation": "Saini S.; Arora S.; Majid S.; Shahryari V.; Chen Y.; Deng G.; Yamamura S.; Ueno K.; Dahiya R.; Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 2011,4(10),1698-1709", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0267", "21836020"]}, {"Citation": "Yu D.; An F.; He X.; Cao X.; Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138. Int J Clin Exp Pathol 2015,8(11),14946-14952", "ArticleIdList": ["26823826"]}, {"Citation": "Zamani M.; Sadeghizadeh M.; Behmanesh M.; Najafi F.; Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer. Phytomedicine 2015,22(10),961-967", "ArticleIdList": ["10.1016/j.phymed.2015.05.071", "26321746"]}, {"Citation": "Sharma R.A.; Euden S.A.; Platton S.L.; Cooke D.N.; Shafayat A.; Hewitt H.R.; Marczylo T.H.; Morgan B.; Hemingway D.; Plummer S.M.; Pirmohamed M.; Gescher A.J.; Steward W.P.; Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004,10(20),6847-6854", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0744", "15501961"]}, {"Citation": "Garcea G.; Berry D.P.; Jones D.J.L.; Singh R.; Dennison A.R.; Farmer P.B.; Sharma R.A.; Steward W.P.; Gescher A.J.; Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 2005,14(1),120-125", "ArticleIdList": ["10.1158/1055-9965.120.14.1", "15668484"]}, {"Citation": "He Z.Y.; Shi C.B.; Wen H.; Li F.L.; Wang B.L.; Wang J.; Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest 2011,29(3),208-213", "ArticleIdList": ["10.3109/07357907.2010.550592", "21314329"]}, {"Citation": "Plummer S.M.; Hill K.A.; Festing M.F.; Steward W.P.; Gescher A.J.; Sharma R.A.; Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 2001,10(12),1295-1299", "ArticleIdList": ["11751448"]}, {"Citation": "Carroll R.E.; Benya R.V.; Turgeon D.K.; Vareed S.; Neuman M.; Rodriguez L.; Kakarala M.; Carpenter P.M.; McLaren C.; Meyskens F.L.; Brenner D.E.; Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 2011,4(3),354-364", "ArticleIdList": ["10.1158/1940-6207.CAPR-10-0098", "21372035"]}, {"Citation": "Irving G.R.B.; Howells L.M.; Sale S.; Kralj-Hans I.; Atkin W.S.; Clark S.K.; Britton R.G.; Jones D.J.L.; Scott E.N.; Berry D.P.; Hemingway D.; Miller A.S.; Brown K.; Gescher A.J.; Steward W.P.; Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration-a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) 2013,6(2),119-128", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0281", "23233733"]}, {"Citation": "Cruz-Correa M.; Shoskes D.A.; Sanchez P.; Zhao R.; Hylind L.M.; Wexner S.D.; Giardiello F.M.; Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006,4(8),1035-1038", "ArticleIdList": ["10.1016/j.cgh.2006.03.020", "16757216"]}, {"Citation": "Cruz-Correa M.; Hylind L.M.; Marrero J.H.; Zahurak M.L.; Murray-Stewart T.; Casero R.A.; Montgomery E.A.; Iacobuzio-Donahue C.; Brosens L.A.; Offerhaus G.J.; Umar A.; Rodriguez L.M.; Giardiello F.M.; Efficacy and safety of curcumin in treatment of intestinal adenomas in patients with familial adenomatous polyposis. Gastroenterology 2018,155(3),668-673", "ArticleIdList": ["10.1053/j.gastro.2018.05.031", "29802852"]}, {"Citation": "Bayet-Robert M.; Kwiatowski F.; Leheurteur M.; Gachon F.; Planchat E.; Abrial C.; Mouret-Reynier M.A.; Durando X.; Barthomeuf C.; Chollet P.; Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 2010,9(1),8-14", "ArticleIdList": ["10.4161/cbt.9.1.10392", "19901561"]}, {"Citation": "Hejazi J.; Rastmanesh R.; Taleban F.A.; Molana S.H.; Hejazi E.; Ehtejab G.; Hara N.; Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study. Nutr Cancer 2016,68(1),77-85", "ArticleIdList": ["10.1080/01635581.2016.1115527", "26771294"]}, {"Citation": "Ide H.; Tokiwa S.; Sakamaki K.; Nishio K.; Isotani S.; Muto S.; Hama T.; Masuda H.; Horie S.; Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate 2010,70(10),1127-1133", "ArticleIdList": ["10.1002/pros.21147", "20503397"]}, {"Citation": "Ledda A.; Belcaro G.; Dugall M.; Luzzi R.; Scoccianti M.; Togni S.; Appendino G.; Ciammaichella G.; Meriva\u00ae, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. Panminerva Med 2012,54(1)(Suppl. 4),17-22", "ArticleIdList": ["23241931"]}, {"Citation": "Elad S.; Meidan I.; Sellam G.; Simaan S.; Zeevi I.; Waldman E.; Weintraub M.; Revel-Vilk S.; Topical curcumin for the prevention of oral mucositis in pediatric patients: case series. Altern Ther Health Med 2013,19(3),21-24", "ArticleIdList": ["23709456"]}, {"Citation": "Kim S.G.; Veena M.S.; Basak S.K.; Han E.; Tajima T.; Gjertson D.W.; Starr J.; Eidelman O.; Pollard H.B.; Srivastava M.; Srivatsan E.S.; Wang M.B.; Curcumin treatment suppresses IKK\u03b2 kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res 2011,17(18),5953-5961", "ArticleIdList": ["10.1158/1078-0432.CCR-11-1272", "21821700"]}, {"Citation": "Santos Filho E.X.; Arantes D.A.C.; Oton Leite A.F.; Batista A.C.; Mendon\u00e7a E.F.; Marreto R.N.; Naves L.N.; Lima E.M.; Valadares M.C.; Randomized clinical trial of a mucoadhesive formulation containing curcuminoids (Zingiberaceae) and Bidens pilosa Linn (Asteraceae) extract (FITOPROT) for prevention and treatment of oral mucositis - phase I study. Chem Biol Interact 2018,291,228-236", "ArticleIdList": ["10.1016/j.cbi.2018.06.010", "29906455"]}, {"Citation": "Arantes D.A.C.; Silva A.C.G.; Freitas N.M.A.; Lima E.M.; Oliveira A.C.; Marreto R.N.; Mendon\u00e7a E.F.; Valadares M.C.; Safety and efficacy of a mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L. extract in the prevention and treatment of radiochemotherapy-induced oral mucositis: Triple-blind, randomized, placebo-controlled, clinical trial. Head Neck 2021,43(12),3922-3934", "ArticleIdList": ["10.1002/hed.26892", "34655135"]}, {"Citation": "Dhillon N.; Aggarwal B.B.; Newman R.A.; Wolff R.A.; Kunnumakkara A.B.; Abbruzzese J.L.; Ng C.S.; Badmaev V.; Kurzrock R.; Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008,14(14),4491-4499", "ArticleIdList": ["10.1158/1078-0432.CCR-08-0024", "18628464"]}, {"Citation": "Epelbaum R.; Schaffer M.; Vizel B.; Badmaev V.; Bar-Sela G.; Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 2010,62(8),1137-1141", "ArticleIdList": ["10.1080/01635581.2010.513802", "21058202"]}, {"Citation": "Pastorelli D.; Fabricio A.S.C.; Giovanis P.; D\u2019Ippolito S.; Fiduccia P.; Sold\u00e0 C.; Buda A.; Sperti C.; Bardini R.; Da Dalt G.; Rainato G.; Gion M.; Ursini F.; Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacol Res 2018,132,72-79", "ArticleIdList": ["10.1016/j.phrs.2018.03.013", "29614381"]}, {"Citation": "Purpura M.; Lowery R.P.; Wilson J.M.; Mannan H.; M\u00fcnch G.; Razmovski-Naumovski V.; Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nutr 2018,57(3),929-938", "ArticleIdList": ["10.1007/s00394-016-1376-9", "28204880"]}, {"Citation": "Sri Ramya P.V.; Angapelly S.; Guntuku L.; Singh Digwal C.; Nagendra Babu B.; Naidu V.G.M.; Kamal A.; Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors. Eur J Med Chem 2017,127,100-114", "ArticleIdList": ["10.1016/j.ejmech.2016.12.043", "28038323"]}, {"Citation": "Rahimi H.R.; Nedaeinia R.; Sepehri Shamloo A.; Nikdoust S.; Kazemi Oskuee R.; Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed 2016,6(4),383-398", "ArticleIdList": ["27516979"]}, {"Citation": "Liu W.; Zhai Y.; Heng X.; Che F.Y.; Chen W.; Sun D.; Zhai G.; Oral bioavailability of curcumin: problems and advancements. J Drug Target 2016,24(8),694-702", "ArticleIdList": ["10.3109/1061186X.2016.1157883", "26942997"]}, {"Citation": "Puneeth H.R.; Ananda H.; Kumar K.S.S.; Rangappa K.S.; Sharada A.C.; Synthesis and antiproliferative studies of curcumin pyrazole derivatives. Med Chem Res 2016,25(9),1842-1851", "ArticleIdList": ["10.1007/s00044-016-1628-5"]}, {"Citation": "Aqil F.; Munagala R.; Jeyabalan J.; Agrawal A.K.; Gupta R.; Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J 2017,19(6),1691-1702", "ArticleIdList": ["10.1208/s12248-017-0154-9", "29047044"]}, {"Citation": "Djurfeldt M.; Hjorth J.; Eppler J.M.; Dudani N.; Helias M.; Potjans T.C.; Bhalla U.S.; Diesmann M.; Hellgren Kotaleski J.; Ekeberg \u00d6.; Run-time interoperability between neuronal network simulators based on the MUSIC framework. Neuroinformatics 2010,8(1),43-60", "ArticleIdList": ["10.1007/s12021-010-9064-z", "20195795"]}, {"Citation": "Bachmeier B.E.; Mohrenz I.V.; Mirisola V.; Schleicher E.; Romeo F.; H\u00f6hneke C.; Jochum M.; Nerlich A.G.; Pfeffer U.; Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NF\u03baB. Carcinogenesis 2008,29(4),779-789", "ArticleIdList": ["10.1093/carcin/bgm248", "17999991"]}, {"Citation": "Shoba G.; Joy D.; Joseph T.; Majeed M.; Rajendran R.; Srinivas P.; Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998,64(4),353-356", "ArticleIdList": ["10.1055/s-2006-957450", "9619120"]}, {"Citation": "Sasaki H.; Sunagawa Y.; Takahashi K.; Imaizumi A.; Fukuda H.; Hashimoto T.; Wada H.; Katanasaka Y.; Kakeya H.; Fujita M.; Hasegawa K.; Morimoto T.; Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 2011,34(5),660-665", "ArticleIdList": ["10.1248/bpb.34.660", "21532153"]}, {"Citation": "Kanai M.; Imaizumi A.; Otsuka Y.; Sasaki H.; Hashiguchi M.; Tsujiko K.; Matsumoto S.; Ishiguro H.; Chiba T.; Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 2012,69(1),65-70", "ArticleIdList": ["10.1007/s00280-011-1673-1", "21603867"]}, {"Citation": "Sunagawa Y.; Hirano S.; Katanasaka Y.; Miyazaki Y.; Funamoto M.; Okamura N.; Hojo Y.; Suzuki H.; Doi O.; Yokoji T.; Morimoto E.; Takahashi T.; Ozawa H.; Imaizumi A.; Ueno M.; Kakeya H.; Shimatsu A.; Wada H.; Hasegawa K.; Morimoto T.; Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. J Nutr Sci Vitaminol (Tokyo) 2015,61(1),37-44", "ArticleIdList": ["10.3177/jnsv.61.37", "25994138"]}, {"Citation": "Morimoto T.; Sunagawa Y.; Katanasaka Y.; Hirano S.; Namiki M.; Watanabe Y.; Suzuki H.; Doi O.; Suzuki K.; Yamauchi M.; Yokoji T.; Miyoshi-Morimoto E.; Otsuka Y.; Hamada T.; Imaizumi A.; Nonaka Y.; Fuwa T.; Teramoto T.; Kakeya H.; Wada H.; Hasegawa K.; Drinkable preparation of Theracurmin exhibits high absorption efficiency-a single-dose, double-blind, 4-way crossover study. Biol Pharm Bull 2013,36(11),1708-1714", "ArticleIdList": ["10.1248/bpb.b13-00150", "24189415"]}, {"Citation": "Vareed S.K.; Kakarala M.; Ruffin M.T.; Crowell J.A.; Normolle D.P.; Djuric Z.; Brenner D.E.; Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008,17(6),1411-1417", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2693", "18559556"]}, {"Citation": "Volak L.P.; Hanley M.J.; Masse G.; Hazarika S.; Harmatz J.S.; Badmaev V.; Majeed M.; Greenblatt D.J.; Court M.H.; Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2013,75(2),450-462", "ArticleIdList": ["10.1111/j.1365-2125.2012.04364.x", "22725836"]}, {"Citation": "J\u00e4ger R.; Lowery R.P.; Calvanese A.V.; Joy J.M.; Purpura M.; Wilson J.M.; Comparative absorption of curcumin formulations. Nutr J 2014,13(1),11", "ArticleIdList": ["10.1186/1475-2891-13-11", "24461029"]}, {"Citation": "Gopi S.; Jacob J.; Varma K.; Jude S.; Amalraj A.; Arundhathy C.A.; George R.; Sreeraj T.R.; Divya C.; Kunnumakkara A.B.; Stohs S.J.; Comparative oral absorption of curcumin in a natural turmeric matrix with two other curcumin formulations: An open-label parallel-arm study. Phytother Res 2017,31(12),1883-1891", "ArticleIdList": ["10.1002/ptr.5931", "29027274"]}, {"Citation": "Schiborr C.; Kocher A.; Behnam D.; Jandasek J.; Toelstede S.; Frank J.; The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 2014,58(3),516-527", "ArticleIdList": ["10.1002/mnfr.201300724", "24402825"]}, {"Citation": "Donaldson K.; Aitken R.; Tran L.; Stone V.; Duffin R.; Forrest G.; Alexander A.; Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006,92(1),5-22", "ArticleIdList": ["10.1093/toxsci/kfj130", "16484287"]}, {"Citation": "Lewinski N.; Colvin V.; Drezek R.; Cytotoxicity of nanoparticles. Small 2008,4(1),26-49", "ArticleIdList": ["10.1002/smll.200700595"]}, {"Citation": "Medina C.; Santos-Martinez M.J.; Radomski A.; Corrigan O.I.; Radomski M.W.; Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 2007,150(5),552-558", "ArticleIdList": ["10.1038/sj.bjp.0707130", "17245366"]}, {"Citation": "Bansal S.S.; Kausar H.; Aqil F.; Jeyabalan J.; Vadhanam M.V.; Gupta R.C.; Ravoori S.; Curcumin implants for continuous systemic delivery: safety and biocompatibility. Drug Deliv Transl Res 2011,1(4),332-341", "ArticleIdList": ["10.1007/s13346-011-0028-0", "25788367"]}, {"Citation": "Kocher A.; Bohnert L.; Schiborr C.; Frank J.; Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. Mol Nutr Food Res 2016,60(7),1555-1563", "ArticleIdList": ["10.1002/mnfr.201501034", "26909743"]}, {"Citation": "Wang K.; Qiu F.; Curcuminoid metabolism and its contribution to the pharmacological effects. Curr Drug Metab 2013,14(7),791-806", "ArticleIdList": ["10.2174/13892002113149990102", "23937173"]}, {"Citation": "Naito M.; Wu X.; Nomura H.; Kodama M.; Kato Y.; Kato Y.; Osawa T.; The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 2002,9(5),243-250", "ArticleIdList": ["10.5551/jat.9.243", "12409634"]}, {"Citation": "Gao Y.; Li J.; Wu L.; Zhou C.; Wang Q.; Li X.; Zhou M.; Wang H.; Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism. J Surg Res 2016,206(1),67-76", "ArticleIdList": ["10.1016/j.jss.2016.07.014", "27916377"]}, {"Citation": "Murugan P.; Pari L.; Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic Clin Pharmacol Toxicol 2006,99(2),122-127", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_447.x", "16918712"]}, {"Citation": "Pari L.; Murugan P.; Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 2007,29(7),881-889", "ArticleIdList": ["10.1080/08860220701540326", "17994458"]}, {"Citation": "Vijaya Saradhi U.V.R.; Ling Y.; Wang J.; Chiu M.; Schwartz E.B.; Fuchs J.R.; Chan K.K.; Liu Z.; A liquid chromatography\u2013tandem mass spectrometric method for quantification of curcuminoids in cell medium and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2010,878(30),3045-3051", "ArticleIdList": ["10.1016/j.jchromb.2010.08.039", "20934924"]}, {"Citation": "Yu Q.; Liu Y.; Wu Y.; Chen Y.; Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells. Biomed Pharmacother 2018,103,1327-1336", "ArticleIdList": ["10.1016/j.biopha.2018.04.143", "29864915"]}, {"Citation": "Gota V.S.; Maru G.B.; Soni T.G.; Gandhi T.R.; Kochar N.; Agarwal M.G.; Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010,58(4),2095-2099", "ArticleIdList": ["10.1021/jf9024807", "20092313"]}, {"Citation": "Garcea G.; Jones D.J.L.; Singh R.; Dennison A.R.; Farmer P.B.; Sharma R.A.; Steward W.P.; Gescher A.J.; Berry D.P.; Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 2004,90(5),1011-1015", "ArticleIdList": ["10.1038/sj.bjc.6601623", "14997198"]}, {"Citation": "Madhavi D.; Kagan D.; Bioavailability of a sustained release formulation of curcumin. Integr Med (Encinitas) 2014,13(3),24-30", "ArticleIdList": ["26770097"]}, {"Citation": "Sharma R.A.; McLelland H.R.; Hill K.A.; Ireson C.R.; Euden S.A.; Manson M.M.; Pirmohamed M.; Marnett L.J.; Gescher A.J.; Steward W.P.; Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001,7(7),1894-1900", "ArticleIdList": ["11448902"]}, {"Citation": "Lao C.D.; Ruffin M.T.; Normolle D.; Heath D.D.; Murray S.I.; Bailey J.M.; Boggs M.E.; Crowell J.; Rock C.L.; Brenner D.E.; Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006,6(1),10", "ArticleIdList": ["10.1186/1472-6882-6-10", "16545122"]}, {"Citation": "Antony B.; Merina B.; Iyer V.S.; Judy N.; Lennertz K.; Joyal S.; A pilot cross-over study to evaluate human oral bioavailability of BCM-95 CG (Biocurcumax ), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 2008,70(4),445-449", "ArticleIdList": ["10.4103/0250-474X.44591", "20046768"]}, {"Citation": "Im K.; Ravi A.; Kumar D.; Kuttan R.; Maliakel B.; An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. J Funct Foods 2012,4(1),348-357", "ArticleIdList": ["10.1016/j.jff.2012.01.004"]}, {"Citation": "Cuomo J.; Appendino G.; Dern A.S.; Schneider E.; McKinnon T.P.; Brown M.J.; Togni S.; Dixon B.M.; Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011,74(4),664-669", "ArticleIdList": ["10.1021/np1007262", "21413691"]}, {"Citation": "Basnet P.; Skalko-Basnet N.; Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011,16(6),4567-4598", "ArticleIdList": ["10.3390/molecules16064567", "21642934"]}, {"Citation": "Asher G.N.; Spelman K.; Clinical utility of curcumin extract. Altern Ther Health Med 2013,19(2),20-22", "ArticleIdList": ["23594449"]}, {"Citation": "Panahi Y.; Saadat A.; Beiraghdar F.; Hosseini Nouzari S.M.; Jalalian H.R.; Sahebkar A.; Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. J Funct Foods 2014,6,615-622", "ArticleIdList": ["10.1016/j.jff.2013.12.008"]}, {"Citation": "Ryan J.L.; Heckler C.E.; Ling M.; Katz A.; Williams J.P.; Pentland A.P.; Morrow G.R.; Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013,180(1),34-43", "ArticleIdList": ["10.1667/RR3255.1", "23745991"]}, {"Citation": "Molana S.-H.; A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer. Int J Cancer Sci Ther 2013,5(10),320-324", "ArticleIdList": ["10.4172/1948-5956.1000222"]}, {"Citation": "Ganiger S.; Malleshappa H.N.; Krishnappa H.; Rajashekhar G.; Ramakrishna Rao V.; Sullivan F.; A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food Chem Toxicol 2007,45(1),64-69", "ArticleIdList": ["10.1016/j.fct.2006.07.016", "16987575"]}, {"Citation": "Sahebkar A.; Henrotin Y.; Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 2016,17(6),1192-1202", "ArticleIdList": ["26814259"]}, {"Citation": "Lamb S.R.; Wilkinson S.M.; Contact allergy to tetrahydrocurcumin. Contact Dermat 2003,48(4),227-227", "ArticleIdList": ["10.1034/j.1600-0536.2003.00062.x", "12786734"]}, {"Citation": "Hsu C.-H.; Cheng A.-L.; The molecular targets and therapeutic uses of curcumin in health and disease. Adv Exp Med Biol 2007,471-480", "ArticleIdList": ["10.1007/978-0-387-46401-5_21"]}, {"Citation": "Cao J.; Jia L.; Zhou H.M.; Liu Y.; Zhong L.F.; Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci 2006,91(2),476-483", "ArticleIdList": ["10.1093/toxsci/kfj153", "16537656"]}, {"Citation": "DiSilvestro R.A.; Joseph E.; Zhao S.; Bomser J.; Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 2012,11(1),79", "ArticleIdList": ["10.1186/1475-2891-11-79", "23013352"]}, {"Citation": "Shep D.; Khanwelkar C.; Gade P.; Karad S.; Efficacy and safety of combination of curcuminoid complex and diclofenac versus diclofenac in knee osteoarthritis. Medicine 2020,99(16),e19723", "ArticleIdList": ["10.1097/MD.0000000000019723", "32311961"]}, {"Citation": "Wang Z.; Sun W.; Huang C.K.; Wang L.; ia M-M.; Cui X.; Hu G.X.; Wang Z.S.; Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes. Drug Dev Ind Pharm 2015,41(4),613-616", "ArticleIdList": ["10.3109/03639045.2014.886697", "24517573"]}, {"Citation": "Babu P.S.; Srinivasan K.; Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997,166(1/2),169-175", "ArticleIdList": ["10.1023/A:1006819605211", "9046034"]}, {"Citation": "Fan C.; Wo X.; Qian Y.; Yin J.; Gao L.; Effect of curcumin on the expression of LDL receptor in mouse macrophages. J Ethnopharmacol 2006,105(1-2),251-254", "ArticleIdList": ["10.1016/j.jep.2005.11.009", "16406419"]}, {"Citation": "Kim D.C.; Kim S.H.; Choi B.H.; Baek N.I.; Kim D.; Kim M.J.; Kim K.T.; Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors. Biol Pharm Bull 2005,28(12),2220-2224", "ArticleIdList": ["10.1248/bpb.28.2220", "16327153"]}, {"Citation": "Imam Z.; Drug induced liver injury attributed to a curcumin supplement. Case Rep Gastroenterol 2019", "ArticleIdList": ["10.1155/2019/6029403"]}, {"Citation": "Borsari M.; Ferrari E.; Grandi R.; Saladini M.; Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorg Chim Acta 2002,328(1),61-68", "ArticleIdList": ["10.1016/S0020-1693(01)00687-9"]}, {"Citation": "Jiao Y.; Wilkinson J.; Di X.; Wang W.; Hatcher H.; Kock N.D.; D\u2019Agostino R.; Knovich M.A.; Torti F.M.; Torti S.V.; Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 2009,113(2),462-469", "ArticleIdList": ["10.1182/blood-2008-05-155952", "18815282"]}, {"Citation": "Vijayalaxmi B. ; Genetic effects of turmeric and curcumin in mice and rats. Mutat Res Genet Toxicol Test 1980,79(2),125-132", "ArticleIdList": ["10.1016/0165-1218(80)90080-4", "7432370"]}, {"Citation": "Abraham S.K.; Kesavan P.; Genotoxicity of garlic, turmeric and asafoetida in mice. Mutat Res 1984,136(1),85-88", "ArticleIdList": ["10.1016/0165-1218(84)90138-1"]}, {"Citation": "Kim D.C.; Ku S.K.; Bae J.S.; Anticoagulant activities of curcumin and its derivative. BMB Rep 2012,45(4),221-226", "ArticleIdList": ["10.5483/BMBRep.2012.45.4.221", "22531131"]}, {"Citation": "Rasyid A.; Lelo A.; The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther 1999,13(2),245-249", "ArticleIdList": ["10.1046/j.1365-2036.1999.00464.x", "10102956"]}, {"Citation": "Rasyid A.; Rahman A.R.A.; Jaalam K.; Lelo A.; Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr 2002,11(4),314-318", "ArticleIdList": ["10.1046/j.1440-6047.2002.00296.x", "12495265"]}, {"Citation": "Tomeh M.; Hadianamrei R.; Zhao X.; A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci 2019,20(5),1033", "ArticleIdList": ["10.3390/ijms20051033", "30818786"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "13"}, {"Year": "2023", "Month": "2", "Day": "23"}, {"Year": "2023", "Month": "3", "Day": "3"}, {"Year": "2024", "Month": "6", "Day": "21", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "10", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "10", "Hour": "0", "Minute": "43"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37559247", "10.2174/0929867331666230809100335", "CMC-EPUB-133477"]}}], "PubmedBookArticle": []}